PureTech Health (PRTC)

• Market cap: $408M
• 1 day: 0.00%
• 5 days: 0.00%
• 1 month: 0.00%
• 3 months: 0.00%
• 6 months: 0.00%
• Year to date: 0.00%
• 1 year: 0.00%
• 5 years: 0.00%
• 10 years: 0.00%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

Employees: 90

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

216% more capital invested

Capital invested by funds: $593K [Q3] → $1.87M (+$1.28M) [Q4]

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

25% more funds holding

Funds holding: 4 [Q3] → 5 (+1) [Q4]

0.14% more ownership

Funds ownership: 0.01% [Q3] → 0.16% (+0.14%) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1